Drug Effective Against Early Breast Cancer

News4 came to Rocky Mountain Cancer Centers’ physician Dev Paul after three studies revealed a stunning drop in the risk of relapse for early-stage breast cancer following the use of the drug Herceptin. Dr. Paul’s explanation of the drug and opinion of the studies’ results were featured in the 10 p.m. broadcast on Wednesday, October 19 and in the 5 a.m. broadcast on Thursday, October 20.